| Health / Medical Topics |
AZD2281
A substance being studied in the treatment of breast, ovarian, and prostate cancers caused by mutations (changes) in the BRCA1 and BRCA2 genes. It is also being studied in the treatment of other types of cancer. It blocks an enzyme involved in many functions of the cell, including the repair of DNA damage. DNA damage may be caused by normal cell actions, UV light, some anticancer drugs, and radiation used to treat cancer. AZD2281 may cause cancer cells to die. It is a type of targeted therapy agent and a type of poly (ADP-ribose) polymerase inhibitor. Also called olaparib and PARP inhibitor AZD2281. (NCI Dictionary)
YOU MAY ALSO LIKE
A substance being studied in the treatment of some types of cancer. AZD2171 may prevent the growth of new blood vessels that…
A substance being studied in the treatment of some types of cancer. AZD0530 blocks enzymes needed for cancer growth. It is a…
A drug used to keep a patient from rejecting a transplanted kidney. It is also used in the treatment of rheumatoid arthritis…
A purine analogue with cytotoxic and immunosuppressive activity. Azathioprine is a prodrug that is converted by hepatic xanthine oxidase to its active…
A substance being studied in the treatment of certain multiple myelomas and other advanced cancers. Azaspirane may block the growth of tumors…
A naturally occurring serine derivative diazo compound with antineoplastic properties, Azaserine functions as a purine antagonist and glutamine analogue (glutamine amidotransferase inhibitor)…
